MoonLake Immunotherapeutics Profile Avatar - Palmy Investing

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It is developing Sonelokimab, a novel investigational Nanobody therapy for the treatment of inflammation. The company is involved in conducting Phas…
Biotechnology
CH, Zug [HQ]

Filings / Resources

Link Index · Filing Reader · 10K/10Q
Loading may take some time.
SEC
2024-03-31 2023-12-31 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-09-30 2021-06-30 2021-03-31
Transcripts

Gather insights into the latest earnings call through our transcripts.

Other Docs/Resources
Transcripts Investor Relations EDGAR MLTX's Industry Healthcare Analysis Biotechnology Analysis CH Analysis Zug Analysis
End of MLTX's Analysis
CIK: 1821586 CUSIP: 61559X104 ISIN: KY61559X1045 LEI: - UEI: -
Secondary Listings
MLTX has no secondary listings inside our databases.